NewEdge Advisors’s LeonaBio Inc LONA Stock Holding History

NewEdge Advisors’s Portfolio LONA Stock Details LONA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-410	Closed	-$4.21K	–	4191
2026 Q1	$4.21K	Buy	410 +360	+720%	+$2.34K	﹤0.01%	3643
2025 Q4	$378	Buy	+50	New	+$229	﹤0.01%	4093

Other funds holding LONA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Kalehua Capital Management Dallas, Texas $174M AUM

Spruce Street Capital New York $510M AUM

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

NewEdge Advisors's LONA Position: Q2 2026 in Review

NewEdge Advisors sold out of LeonaBio Inc (LONA) in Q2 2026, closing a stake of 410 shares — an estimated $4.21K sold.

NewEdge Advisors first reported a position in LONA in Q4 2025 and held it in 2 quarters. The position peaked at $4.21K in Q1 2026. 44 funds tracked by Wall St. Rank hold LONA as of Q2 2026.

NewEdge Advisors reported no remaining LeonaBio Inc position as of Q2 2026 after selling out during the quarter.
NewEdge Advisors sold 410 LeonaBio Inc shares in Q2 2026, an estimated $4.21K.
NewEdge Advisors first reported a position in LeonaBio Inc in Q4 2025 and held it in 2 quarters.
NewEdge Advisors's LeonaBio Inc position peaked at $4.21K in Q1 2026.
44 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.